vs
KINGSWAY FINANCIAL SERVICES INC（KFS）与REGENXBIO Inc.（RGNX）财务数据对比。点击上方公司名可切换其他公司
KINGSWAY FINANCIAL SERVICES INC的季度营收约是REGENXBIO Inc.的1.3倍（$38.6M vs $30.3M），KINGSWAY FINANCIAL SERVICES INC净利率更高（-4.1% vs -221.3%，领先217.2%），REGENXBIO Inc.同比增速更快（43.0% vs 30.1%），过去两年REGENXBIO Inc.的营收复合增速更高（39.4% vs 21.4%）
金斯威金融服务公司是一家专业金融控股企业，主要提供财产和意外伤害保险产品，包括个人车险、商业责任险、财产险等，核心市场覆盖北美地区，服务个人消费者、小微企业主及特定商业客户群体。
REGENXBIO Inc.是一家临床阶段生物技术企业，专注于开发针对罕见及严重遗传疾病的突破性基因疗法。公司拥有专有的腺相关病毒载体技术，既向全球生物制药合作伙伴提供技术授权，也自主推进多疾病领域的基因疗法管线研发。
KFS vs RGNX — 直观对比
营收规模更大
KFS
是对方的1.3倍
$30.3M
营收增速更快
RGNX
高出12.9%
30.1%
净利率更高
KFS
高出217.2%
-221.3%
两年增速更快
RGNX
近两年复合增速
21.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $38.6M | $30.3M |
| 净利润 | $-1.6M | $-67.1M |
| 毛利率 | — | — |
| 营业利润率 | 0.8% | -190.0% |
| 净利率 | -4.1% | -221.3% |
| 营收同比 | 30.1% | 43.0% |
| 净利润同比 | -7.8% | -31.2% |
| 每股收益（稀释后） | $-0.07 | $-1.30 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收KFSRGNX
| Q4 25 | $38.6M | $30.3M | ||
| Q3 25 | $37.2M | $29.7M | ||
| Q2 25 | $30.9M | $21.4M | ||
| Q1 25 | $28.3M | $89.0M | ||
| Q4 24 | $29.6M | $21.2M | ||
| Q3 24 | $27.1M | $24.2M | ||
| Q2 24 | $26.4M | $22.3M | ||
| Q1 24 | $26.2M | $15.6M |
净利润KFSRGNX
| Q4 25 | $-1.6M | $-67.1M | ||
| Q3 25 | $-2.4M | $-61.9M | ||
| Q2 25 | $-3.2M | $-70.9M | ||
| Q1 25 | $-3.1M | $6.1M | ||
| Q4 24 | $-1.5M | $-51.2M | ||
| Q3 24 | $-2.3M | $-59.6M | ||
| Q2 24 | $-2.2M | $-53.0M | ||
| Q1 24 | $-2.3M | $-63.3M |
毛利率KFSRGNX
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 70.2% | ||
| Q3 24 | — | 48.8% | ||
| Q2 24 | — | 52.5% | ||
| Q1 24 | — | 72.6% |
营业利润率KFSRGNX
| Q4 25 | 0.8% | -190.0% | ||
| Q3 25 | -2.3% | -176.3% | ||
| Q2 25 | -3.6% | -296.3% | ||
| Q1 25 | -2.5% | 13.6% | ||
| Q4 24 | 6.5% | -242.1% | ||
| Q3 24 | -2.5% | -256.6% | ||
| Q2 24 | 0.5% | -251.3% | ||
| Q1 24 | 2.9% | -408.8% |
净利率KFSRGNX
| Q4 25 | -4.1% | -221.3% | ||
| Q3 25 | -6.5% | -208.3% | ||
| Q2 25 | -10.2% | -331.8% | ||
| Q1 25 | -10.9% | 6.8% | ||
| Q4 24 | -5.0% | -241.3% | ||
| Q3 24 | -8.5% | -246.3% | ||
| Q2 24 | -8.3% | -237.7% | ||
| Q1 24 | -8.9% | -405.4% |
每股收益（稀释后）KFSRGNX
| Q4 25 | $-0.07 | $-1.30 | ||
| Q3 25 | $-0.10 | $-1.20 | ||
| Q2 25 | $-0.13 | $-1.38 | ||
| Q1 25 | $-0.13 | $0.12 | ||
| Q4 24 | $-0.08 | $-0.99 | ||
| Q3 24 | $-0.10 | $-1.17 | ||
| Q2 24 | $-0.08 | $-1.05 | ||
| Q1 24 | $-0.09 | $-1.38 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $8.5M | $230.1M |
| 总债务越低越好 | $70.7M | — |
| 股东权益账面价值 | $15.2M | $102.7M |
| 总资产 | $231.5M | $453.0M |
| 负债/权益比越低杠杆越低 | 4.66× | — |
8季度趋势，按日历期对齐
现金及短期投资KFSRGNX
| Q4 25 | $8.5M | $230.1M | ||
| Q3 25 | $9.5M | $274.2M | ||
| Q2 25 | $12.3M | $323.3M | ||
| Q1 25 | $6.5M | $267.9M | ||
| Q4 24 | $5.7M | $234.7M | ||
| Q3 24 | $6.7M | $255.5M | ||
| Q2 24 | $9.8M | $290.4M | ||
| Q1 24 | $12.3M | $338.7M |
总债务KFSRGNX
| Q4 25 | $70.7M | — | ||
| Q3 25 | $70.7M | — | ||
| Q2 25 | $58.3M | — | ||
| Q1 25 | $59.5M | — | ||
| Q4 24 | $57.5M | — | ||
| Q3 24 | $58.5M | — | ||
| Q2 24 | $47.3M | — | ||
| Q1 24 | $47.1M | — |
股东权益KFSRGNX
| Q4 25 | $15.2M | $102.7M | ||
| Q3 25 | $16.6M | $161.5M | ||
| Q2 25 | $17.4M | $213.7M | ||
| Q1 25 | $5.5M | $274.2M | ||
| Q4 24 | $8.4M | $259.7M | ||
| Q3 24 | $9.9M | $301.4M | ||
| Q2 24 | $20.7M | $348.3M | ||
| Q1 24 | $23.6M | $390.7M |
总资产KFSRGNX
| Q4 25 | $231.5M | $453.0M | ||
| Q3 25 | $235.1M | $525.2M | ||
| Q2 25 | $207.7M | $581.0M | ||
| Q1 25 | $192.1M | $490.9M | ||
| Q4 24 | $186.6M | $466.0M | ||
| Q3 24 | $191.1M | $519.1M | ||
| Q2 24 | $192.3M | $569.4M | ||
| Q1 24 | $198.0M | $629.2M |
负债/权益比KFSRGNX
| Q4 25 | 4.66× | — | ||
| Q3 25 | 4.25× | — | ||
| Q2 25 | 3.34× | — | ||
| Q1 25 | 10.91× | — | ||
| Q4 24 | 6.84× | — | ||
| Q3 24 | 5.88× | — | ||
| Q2 24 | 2.29× | — | ||
| Q1 24 | 2.00× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-3.0K | $-52.3M |
| 自由现金流经营现金流 - 资本支出 | — | $-52.8M |
| 自由现金流率自由现金流/营收 | — | -174.0% |
| 资本支出强度资本支出/营收 | — | 1.7% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-126.4M |
8季度趋势，按日历期对齐
经营现金流KFSRGNX
| Q4 25 | $-3.0K | $-52.3M | ||
| Q3 25 | $1.5M | $-56.0M | ||
| Q2 25 | $337.0K | $-49.3M | ||
| Q1 25 | $-1.8M | $33.6M | ||
| Q4 24 | $1.1M | $-31.6M | ||
| Q3 24 | $368.0K | $-40.5M | ||
| Q2 24 | $557.0K | $-45.5M | ||
| Q1 24 | $249.0K | $-55.5M |
自由现金流KFSRGNX
| Q4 25 | — | $-52.8M | ||
| Q3 25 | $1.3M | $-56.5M | ||
| Q2 25 | — | $-49.7M | ||
| Q1 25 | — | $32.6M | ||
| Q4 24 | — | $-32.7M | ||
| Q3 24 | — | $-40.9M | ||
| Q2 24 | — | $-46.0M | ||
| Q1 24 | — | $-56.0M |
自由现金流率KFSRGNX
| Q4 25 | — | -174.0% | ||
| Q3 25 | 3.4% | -189.9% | ||
| Q2 25 | — | -232.8% | ||
| Q1 25 | — | 36.6% | ||
| Q4 24 | — | -154.2% | ||
| Q3 24 | — | -168.9% | ||
| Q2 24 | — | -206.2% | ||
| Q1 24 | — | -358.5% |
资本支出强度KFSRGNX
| Q4 25 | — | 1.7% | ||
| Q3 25 | 0.5% | 1.7% | ||
| Q2 25 | — | 1.8% | ||
| Q1 25 | — | 1.2% | ||
| Q4 24 | — | 5.1% | ||
| Q3 24 | 0.0% | 1.3% | ||
| Q2 24 | — | 2.1% | ||
| Q1 24 | — | 3.6% |
现金转化率KFSRGNX
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 5.53× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
KFS
| Other | $14.8M | 38% |
| Roundhouse Electric Equipment Co Inc | $9.7M | 25% |
| MLC Plumbing LLC | $5.7M | 15% |
| Systems Products International Incspi | $3.8M | 10% |
| Advanced Plumbing And Drain | $2.9M | 8% |
| Southside Plumbing | $1.7M | 4% |
RGNX
| Novartis Gene Therapies | $24.2M | 80% |
| Nippon Shinyaku Collaboration And License Agreement | $4.3M | 14% |
| Nippon Shinyaku Services | $1.4M | 5% |
